A
Anbio Biotechnology
NASDAQ:NNNN
Anbio Biotechnology
NASDAQ:NNNN
Price:
27.55
USD
6.12%
Market Closed
Market Cap:
$4B
Income Statement
Earnings Waterfall
Anbio Biotechnology
Anbio Biotechnology
Income Statement
Anbio Biotechnology
Anbio Biotechnology
Currency:
| Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
13
N/A
|
8
-35%
|
13
+56%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(5)
|
(2)
|
(3)
|
|
| Gross Profit |
7
N/A
|
6
-19%
|
10
+72%
|
|
| Operating Income | ||||
| Operating Expenses |
(2)
|
(4)
|
(5)
|
|
| Selling, General & Administrative |
(1)
|
(3)
|
(4)
|
|
| Research & Development |
(0)
|
(0)
|
(1)
|
|
| Operating Income |
6
N/A
|
2
-64%
|
5
+169%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
0
|
0
|
1
|
|
| Total Other Income |
0
|
0
|
0
|
|
| Pre-Tax Income |
6
N/A
|
2
-59%
|
6
+160%
|
|
| Net Income | ||||
| Tax Provision |
0
|
0
|
0
|
|
| Income from Continuing Operations |
6
|
2
|
6
|
|
| Net Income (Common) |
6
N/A
|
2
-59%
|
6
+160%
|
|
| EPS (Diluted) |
0.13
N/A
|
0.06
-54%
|
0.14
+133%
|
|
Switch to:
Switch to:
See Also
Discover More
